Prognostic value or seric levels of soluble CD25 and CD23 receptors in B-CLL. Report on 109 patients

被引：0
|
作者：
Desablens, B [1 ]
Capiod, JC [1 ]
Gouilleux, V [1 ]
Fuentes, V [1 ]
Garidi, R [1 ]
Claisse, JF [1 ]
机构：
[1] CHU AMIENS,F-80054 AMIENS,FRANCE
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1062 / 1062
页数：1
相关论文
共 50 条
  • [21] Predictive value of soluble CD25 during chemotherapy in Breast cancer patients
    Mbengue, B.
    Ndiaye, R.
    Diouf, D.
    Niang, D. G. M.
    Mbow, M.
    Ka, S.
    Niang, Sylla M.
    Gueye, P. M.
    Diallo, Ndiaye R.
    Dem, A.
    Dieye, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1541 - 1541
  • [22] Doubling time of soluble CD23 is a biological marker for disease progression of stage a B-CLL
    Meuleman, N
    Lagneaux, L
    Dejeneffe, M
    Benani, J
    Tondreau, T
    Sarfati, M
    Bron, D
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 82 - 82
  • [23] Tumor burden and serum level of soluble CD25, CD8, CD23, CD54 and CD44 in non-Hodgkin's lymphoma
    Pérez-Encinas, M
    Villamayor, M
    Campos, A
    González, S
    Bello, JL
    HAEMATOLOGICA, 1998, 83 (08) : 752 - 754
  • [24] CD23 antigen expression on B lymphocytes and soluble CD23 levels in peripheral blood of high-risk type 1 diabetes subjects
    Kretowski, A
    Szelachowska, M
    Pietruczuk, M
    Kinalska, I
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1999, 49 (01) : 78 - 81
  • [25] Prognostic value of CD4~+CD25~+ Tregs as a valuable biomarker for patients with sepsis in ICU
    Kun Chen
    Qiu-xiang Zhou
    Hong-wei Shan
    Wen-fang Li
    Zhao-fen Lin
    World Journal of Emergency Medicine, 2015, (01) : 40 - 43
  • [26] Prognostic value of CD4(+)CD25(+) Tregs as a valuable biomarker for patients with sepsis in ICU
    Chen, Kun
    Zhou, Qiu-xiang
    Shan, Hong-wei
    Li, Wen-fang
    Lin, Zhao-fen
    WORLD JOURNAL OF EMERGENCY MEDICINE, 2015, 6 (01) : 40 - 43
  • [27] SOLUBLE CD8, CD25 AND CD30 ANTIGENS AS PROGNOSTIC MARKERS IN PATIENTS WITH UNTREATED HODGKINS LYMPHOMA
    GAUSE, A
    JUNG, W
    SCHMITS, R
    TSCHIERSCH, A
    SCHOLZ, R
    POHL, C
    HASENCLEVER, D
    DIEHL, V
    PFREUNDSCHUH, M
    ANNALS OF ONCOLOGY, 1992, 3 : S49 - S52
  • [28] Expression of activation markers (CD25 and CD69) on B malignant cell refers to IL-2 and sIL-2R serum level in patients with B-CLL.
    Rolinski, JM
    Dmoszynska, A
    Krawczyk, P
    Wasik, E
    Borzecki, A
    BLOOD, 1999, 94 (10) : 304B - 304B
  • [29] Doubling time of soluble CD23 is an additional marker in CLL patients expressing or not ZAP-70
    Meuleman, N
    Lagneaux, L
    Dejeneffe, M
    Delforge, A
    Bron, D
    ANNALS OF ONCOLOGY, 2005, 16 : 202 - 202
  • [30] CD5, CD10, CD23, and CD25 negative monoclonal small B-cell leukemia: Is this primary marginal zone leukemia?
    Sheikh, SS
    Al-Kuraya, KA
    Kallakury, BVS
    Hartmann, DP
    Bagg, A
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 112 (04) : 562 - 562
12345